Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenously given methylprednisolone in refractory asthma

H A Krouse, S M Santiago, W B Klaustermeyer

    The Western Journal of Medicine
    |February 1, 1980
    PubMed
    Summary

    For most adults with severe asthma, three days of high-dose intravenous methylprednisolone provides sustained lung function improvement. Longer treatment may be needed for a few patients requiring careful monitoring.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ultra-processed foods consumption among inmates in a women's prison in São Paulo, Brazil.

    Revista espanola de sanidad penitenciaria·2019
    Same author

    Effect of high dose inhaled corticosteroids on cell mediated immunity in patients with asthma.

    Allergologia et immunopathologia·2012
    Same author

    Serum IgE and eosinophil count in allergic rhinitis--analysis using a modified Bayes' theorem.

    Allergologia et immunopathologia·2011
    Same author

    New-variant hereditary angioedema in three brothers with normal C1 esterase inhibitor level and function.

    Allergy·2004
    Same author

    Hypercapnic respiratory failure in COPD patients: response to therapy.

    Chest·2000
    Same author

    Facial edema, oral ulcers, and a cutaneous eruption following a dental procedure utilizing diflunisal and mepivacaine.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·1999

    Area of Science:

    • Pulmonology
    • Pharmacology
    • Clinical Medicine

    Background:

    • Corticosteroid-dependent asthma requires effective treatment strategies.
    • High-dose methylprednisolone is used for severe asthma exacerbations.
    • Optimizing treatment duration for methylprednisolone is crucial for patient outcomes.

    Purpose of the Study:

    • To compare the efficacy of two high-dose methylprednisolone regimens in adult refractory corticosteroid-dependent asthmatics.
    • To evaluate the time course of respiratory function improvement with different treatment durations.
    • To determine the optimal duration of intravenous methylprednisolone therapy.

    Main Methods:

    • Randomized controlled trial comparing 3-day vs. 10-day intravenous methylprednisolone (125 mg every 6 hours).
    • Inclusion of adult patients with refractory corticosteroid-dependent asthma.
    • Assessment of spirometric parameters including Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and Forced Expiratory Flow between 25% and 75% of vital capacity (FEF25%-75%).

    Main Results:

    • Significant improvement in FVC, FEV1, and FEF25%-75% over ten days in both treatment groups (P<.005).
    • No significant differences in spirometric values were observed between the 3-day and 10-day methylprednisolone groups at any time point (P>.2).
    • Three days of high-dose methylprednisolone demonstrated obvious and sustained ventilatory improvement in most patients.

    Conclusions:

    • A three-day course of high-dose intravenous methylprednisolone is generally sufficient for achieving sustained ventilatory improvement in adult corticosteroid-dependent asthmatics.
    • Longer treatment durations may be necessary for a subset of patients, necessitating close clinical and spirometric monitoring for potential relapse.
    • Individualized treatment approaches are recommended for managing severe asthma exacerbations with high-dose corticosteroids.

    Related Experiment Videos